Skip to main content


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Full Schedule

Full Schedule

  • Tuesday, September 10, 2024
  • 7:00 AM – 7:45 AM ET
    STEP & ESP Gathering
  • 7:00 AM – 8:00 AM ET
    Continental Breakfast
  • 7:00 AM – 3:30 PM ET
    ACCP Registration Open
  • 8:00 AM – 9:30 AM ET
    Symposium 11: Hot Topics: Current Bioethical Challenges in Clinical Research & Drug Development: Joint ACCP-NYU Grossman School of Medicine Symposium

    Co-Chair & Faculty: Alison Bateman-House, PhD (she/her/hers) – New York Univ Grossman School of Medicine

    Co-Chair & Faculty: Kenneth T. Moore, MA, MS (he/him/his) – Janssen Scientific Affairs LLC, a Johnson & Johnson Co

    Faculty: Kellie Owens, PhD (she/her/hers) – New York Univ Grossman School of Medicine

    Clinical Trial Designs

    CE: 1.5

  • 8:00 AM – 9:30 AM ET
    Symposium 12: Towards Optimal Dosing in Malnutrition: Innovations for Improved Health Outcomes

    Co-Chair & Faculty: Vikram Gota, MD – Advance Ctr for Treatment Research & Education in Cancer, Tata Memorial Ctr

    Co-Chair & Faculty: Meenakshi Srinivasan, PharmD (she/her/hers) – GSK plc

    Faculty: Rada Savic, PhD (she/her/hers) – Univ of California San Francisco

    Faculty: Erik Sjögren, PhD – Pharmetheus ab

    Specific Populations

    CE: 1.5

  • 9:30 AM – 10:00 AM ET
    Coffee & Networking Break
  • 10:00 AM – 11:30 AM ET
    Symposium 13: Advancements in Understanding Drug-induced Hypersensitivity Reactions

    Chair & Faculty: Santiago Alvarez-Arago, MD (he/him/his) – Johns Hopkins Univ School of Medicine

    Faculty: Melanie C. Dispenza, MD – Johns Hopkins Univ School of Medicine

    Faculty: Elizabeth Phillips, MD – Vanderbilt Univ Medical Ctr

    Translational Clinical Pharmacology

    CE: 1.5

  • 10:00 AM – 11:30 AM ET
    Symposium 14: At the Precipice of Induction-based Drug-Drug Interactions: An Opportunity to Define the Path Forward

    Co-Chair & Faculty: Diane Ramsden, BSc (she/her/hers) – Korrobio Inc

    Co-Chair & Faculty: Xinning Yang, PhD (he/him/his) – US Food & Drug Administration

    Faculty: Tamara D. Cabalu, PhD – Merck & Co Inc

    Translational Clinical Pharmacology

    CE: 1.5

  • 11:30 AM – 1:30 PM ET
    Lunch Buffet
  • 11:45 AM – 1:15 PM ET
    Lunch & Annual Business Meeting (Open to All)
  • 1:30 PM – 3:00 PM ET
    Symposium 15: Project Optimus: A Paradigm Shift in Quantitative Clinical Pharmacology or Business as Usual? Part 1

    Co-Chair & Faculty: Nan Zheng, PhD – US Food & Drug Administration

    Co-Chair & Faculty: Honghui Zhou, PhD – Jazz Pharmaceuticals Inc

    Faculty: Brian Booth, PhD – US Food & Drug Administration

    Faculty: Chunze Li, PhD – Genentech Inc

    Faculty: Bernd Meibohm, PhD – Univ of Tennessee Health Science Ctr

    Faculty: Weirong Wang, PhD – Johnson & Johnson Innovative Medicine

    Clinical Trial Designs

    CE: 1.5

  • 1:30 PM – 3:00 PM ET
    Symposium 16: New Perspectives on Drug Evaluation in Older Adults

    Co-Chair & Faculty: Federica Ferrari, MD, MSc, PhD – Univ of Pavia - IRCCS Mondino Fdtn

    Co-Chair & Faculty: Amit P. Pai, PharmD – Univ of Michigan

    Faculty: Luigi Ferrucci, MD, PhD – National Inst of Health

    Faculty: Rajanikanth Madabushi, PhD – US Food & Drug Administration

    Specific Populations

    CE: 1.5

  • 3:00 PM – 3:30 PM ET
    Coffee & Networking Break
  • 3:30 PM – 5:00 PM ET
    Symposium 15: Project Optimus: A Paradigm Shift in Quantitative Clinical Pharmacology or Business as Usual? Part 2

    Co-Chair & Faculty: Nan Zheng, PhD – US Food & Drug Administration

    Co-Chair & Faculty: Honghui Zhou, PhD – Jazz Pharmaceuticals Inc

    Faculty: Brian Booth, PhD – US Food & Drug Administration

    Faculty: Chunze Li, PhD – Genentech Inc

    Faculty: Bernd Meibohm, PhD – Univ of Tennessee Health Science Ctr

    Faculty: Weirong Wang, PhD – Johnson & Johnson Innovative Medicine

    Clinical Trial Designs

    CE: 1.5

  • 3:30 PM – 5:00 PM ET
    Symposium 17: Hot Topics: Advancements in Antisense Oligonucleotide Development: Challenges, Strategies & Novel Approaches

    Co-Chair & Faculty: Reena Kartha, MS, PhD (she/her/hers) – Ctr for Orphan Drug Research/Coll of Pharmacy/Univ of Minnesota

    Co-Chair & Faculty: Natalie Schmitz, PharmD, PhD – Biogen

    Faculty: Michael Monine, PhD – Biogen

    Faculty: Emily Noonan Place, PhD, MPH – Aclairo Pharmaceutical Development Group Inc

    Translational Clinical Pharmacology

    CE: 1.5